Insulet (PODD) Common Equity (2010 - 2026)

Insulet's Common Equity history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• Quarterly Common Equity fell 2.1% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 2.1% YoY) and the FY2025 annual result came in at $1.5 billion, up 25.06% from the prior year.
• Common Equity was $1.3 billion for Q1 2026 at Insulet, down from $1.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.5 billion in Q4 2025 and bottomed at $422.4 million in Q2 2022.
• A 5-year average of $899.1 million and a median of $790.7 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity decreased 23.68% — and 2024, when it soared 84.03%.
• Insulet's Common Equity stood at $476.4 million in 2022, then soared by 53.8% to $732.7 million in 2023, then soared by 65.36% to $1.2 billion in 2024, then increased by 25.06% to $1.5 billion in 2025, then fell by 14.03% to $1.3 billion in 2026.
• Business Quant data shows PODD's Common Equity at $1.3 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.4 billion in Q3 2025.